Document Type: Final File

Authors

1 Drug Design and Development Research Center, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran

2 Department of Biotechnology, Iranian Research Organization for Science and Technology, Tehran 33535-111, Islamic Republic of Iran

3 4Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran

Abstract

Cancer is a leading cause of death worldwide. Many heterocyclic cores are present in the structures of clinically approved anticancer drugs. Meanwhile, benzothiazoles have been reported as one of the most important heterocyclic scaffolds in previously reported anticancer agents in the literature. Therefore, in this report, a novel series of 2-phenyl benzothiazole derivatives was synthesized, biologically evaluated against breast cancer cell line (T47D) and compared with etoposide as a reference drug.  The anticancer activities were evaluated by MTT colorimetric assay. Among all tested compounds, N-(4-(6-methoxybenzo[d]thiazol-2-yl)phenyl)acetamide illustrated the most potent cytotoxic activity.

Keywords

  1. Raju G.N., Karumudi B.S., and Rao N.R. Benzothiazole - Versatile heterocyclic nucleus in medicinal chemistry: A review. Int. J. Pharm. Chem., 5 (4): 104-114 (2015).
  2. Keri R.S., Patil M.R., Patil S.A., and Budagumpi S. A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. Eur. J. Med. Chem., 89 (7): 207-251 (2015).
  3. Liu D.-C., Zhang H.-J., Jin C.-M., and Quan Z.S. Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticonvulsant agents. Molecules, 21: 164-177 (2016).
  4. Gagoria J., Verma P.K., and Khatkar A. Anticonvulsant and neurological profile of benzothiazoles: a mini-review. Cent. Nerv. Syst. Agents Med. Chem. 15(1):11-16 (2015).
  5. Zaheen Hassan M., Khan S.A., and Amir M. Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl)amides as anticonvulsant and neuroprotective. Eur. J. Med. Chem., 58: 206-213 (2012).
  6. Keri R.S., Quintanova C., Marques S.M., Esteves A.R., Cardoso S.M., and Santos M.A. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease. Bioorg. Med. Chem., 21(15): 4559-4569 (2013).
  7. Rahim F., Samreen, Taha M., Saad S.M., Perveen S., Khan M., Alam M.T., Khan K.M., and Choudhary M.I. Antileishmanial Activities of Benzothiazole Derivatives. J. Chem. Soc. Pak., 37 (1): 157-161 (2015).
  8. Shah P., Dhameliya T.M., Bansal R., Nautiyal M.,  Kommi D.N., Jadhavar P.S., Sridevi J.P.,  Yogeeswari P., Sriram D.  and  Chakraborti A.K. N-Arylalkylbenzo[d]thiazole-2-carboxamides as anti-mycobacterial agents: design, new methods of synthesis and biological evaluation. Med. Chem. Commun.  5: 1489-1495 (2014).
  9. Telvekar V.N., Bairwa V.K., Satardekar K., and Bellubi A. Novel 2-(2-(4-aryloxybenzylidene) hydrazinyl) benzothiazole derivatives as anti-tubercular agents. Bioorg. Med. Chem. Lett., 22 (1): 649-652 (2012).

10.Sarkar S., Siddiqui A.A., Saha S.J., De R., Mazumder S., Banerjee C., Iqbal M.S., Nag S., Adhikari S., and Bandyopadhyay U. Antimalarial Activity of Small-Molecule Benzothiazole Hydrazones. Antimicrob. Agents Chemother., 60(7): 4217-4228 (2016).

11.Zhao S., Zhao L., Zhang X., Liu C., Hao C., Xie H., Sun B., Zhao D., and Cheng M. Design, synthesis, and structure-activity relationship studies of benzothiazole derivatives as antifungal agents. Eur. J. Med. Chem. 10(123): 514-522 (2016).

12.Shafi S., Alam M.M., Mulakayala N., Mulakayala C., Vanaja G., Kalle A.M., Pallu R., and Alam M.S. Synthesis of novel 2-mercapto benzothiazole and 1, 2, 3-triazole based bis-heterocycles: their anti-inflammatory and anti-nociceptive activities. Eur. J. Med. Chem., 49: 324-333 (2012).

13.Xiang P., Zhou T., Wang L., Sun C.Y., Hu J., Zhao Y.L., and Yang L. Novel benzothiazole, benzimidazole and benzoxazole derivatives as potential antitumor agents: synthesis and preliminary in vitro biological evaluation. Molecules. 17(1): 873-883 (2012).

14.Shi D.F., Bradshaw T.D., Wrigley S., McCall C.J., Lelieveld P., Fichtner I., and Stevens M.F. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl) benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J. Med. Chem., 39 (17): 3375-3384 (1996).

15.Prajapati N.P.,  Vekariya R.H.,  Borada  M.A., and  Patel H.D. Recent advances in the synthesis of 2-substituted benzothiazoles: a review. RSC Adv., 4: 60176-60208 (2014) and references cited therein.

16.Kumar V., Sana V.K., Singh A.T., Jaggi M., Sharma P.K., Irchhaiya R., and Burman A.C. Synthesis and Anti Cancer Activity of Pyrido[2,3-c]Pyridazine Derivatives. J. Sci. I. R. Iran., 20 (4): 325-329 (2009).

17.Fereidoonnezhad M., Faghih Z., Mojaddami A., Tabaei S.M.H., and Rezaei Z. Novel Approach Synthesis, Molecular Docking and Cytotoxic Activity Evaluation of N-phenyl-2,2-dichloroacetamide Derivatives as Anticancer Agents. J. Sci. I. R. Iran., 27 (1): 39-49 (2016).

18.Bhuva H.A., and Kini S.G. Synthesis, anticancer activity and docking of some substituted benzothiazoles as tyrosine kinase inhibitors. J. Mol. Graph. Model, 29 (1): 32-37 (2010).

19.Yates P.C., McCall C.J., and Stevens M.F.G. Structural studies on benzothiazoles. Crystal and molecular structure of 5,6-dimethoxy-2-(4-methoxyphenyl)benzothiazole and molecular orbital calculations on related compounds. Tetrahedron, 47:6493-6502 (1991).

20.Noushini S., Mahdavi M., Firoozpour L., Moghimi S., Shafiee A., and Foroumadi A. Efficient multi-component synthesis of 1,4-benzodiazepine-3, 5-diones: a Petasis-based approach. Tetrahedron, 71 (36): 6272-6275 (2015).

21.Moghimi S., Goli-Garmroodi F., Pilali H., Mahdavi M., Firoozpour L., Nadri H., Moradi H., Asadipour A., Shafiee A., and Foroumadi A. Synthesis and anti-acetylcholinesterase activity of benzotriazinone-triazole systems. J. Chem. Sci. 128 (9): 1445-1449 (2016).

22.Yahya-Meymandi A., Nikookar H., Moghimi S., Mahdavi M., Firoozpour L., Asadipour A., Ranjbar P.R., and Foroumadi A. An efficient four-component reaction for the synthesis of chromeno [4,3-b] quinolone derivatives. J. Iran Chem. Soc., 14 (4): 771-775 (2017).

23.Sayahi M.H., Baghersaei S., Goli F., Moghimi S., Mahdavi M., Firoozpour L., Shafiee A., and Foroumadi A. An Efficient Four-Step Approach Toward Fused Triazino [1,6-a] Quinazolines. Comb. Chem. High Throughput Screen., 19 (3): 189-192 (2016).

24.Ketabforoosh S.H.M.E., Kheirollahi A., Safavi M., Esmati N., Ardestani S.K., Emami S., Firoozpour L., Shafiee A., and Foroumadi A. Synthesis and Anti‐Cancer Activity Evaluation of New Dimethoxylated Chalcone and Flavanone Analogs. Arch. Pharm., 347 (11): 853-860 (2014).

25.Mohammadhosseini N., Pordeli M., Safavi M., Firoozpour L., Amin F., Ardestani S.K., Edraki N., Shafiee A., and Foroumadi A. Novel N-2-(Furyl)-2-(Chlorobenzyloxyimino) Ethyl Piperazinyl Quinolones: Synthesis, Cytotoxic Evaluation and Structure-Activity Relationship. Iran J. Pharm. Res., 14 (4): 1095-1103 (2015).

26.Mahdavi M., Shirazi M.S., Taherkhani R., Saeedi M., Alipour E., Moghadam F.H., Moradi A., Nadri H., Firoozpour L., Shafiee A., and Foroumadi A. Synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl) thiourea derivatives as 15-lipoxygenase inhibitors. ‎Eur. J. Med. Chem., 82: 308-313 (2014).

27.Martins A.F., Morfin J.-F, Kubíčková A., Kubíček V., Buron F., Suzenet F., Salerno M., Lazar A.N., Duyckaerts C., Arlicot N., Guilloteau D. Geraldes C.F.G.C., and Tóth E. PiB-Conjugated, Metal-Based Imaging Probes: Multimodal Approaches for the Visualization of β-Amyloid Plaques. ACS Med. Chem. Lett., 4: 436-440 (2013).

28.Hutchinson I., Chua M.S., Browne H.L., Trapani V., Bradshaw T.D., Westwell A.D., and Stevens M.F. Antitumor benzothiazoles. synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl) benzothiazoles. J. Med. Chem., 44 (9): 1446-1455 (2001).

29.Bellamy F.D., and Ou K. Selective reduction of aromatic nitro compounds with stannous chloride in non acidic and non aqueous medium. Tetrahedron Lett., 25 (8): 839-842 (1984).

30.Henriksen G., Hauser A.I., Westwell A.D., Yousefi B.H., Schwaiger M., Drzezga A., and Wester H.J. Metabolically Stabilized Benzothiazoles for Imaging of Amyloid Plaques. J. Med. Chem., 50 (6): 1087-1089 (2007).

31.Serdons K., Verduyckt T., Vanderghinste D., Borghgraef P., Cleynhens J., Van Leuven F., Kung H., Bormans G., and Verbruggen A. 11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid β in Alzheimer's disease. Eur. J. Med. Chem., 44 (4): 1415-1426 (2009).

32.Dianat S., Mahdavi M., Moghimi S., Mouradzadegun A., Shafiee A., and Foroumadi A. Combined isocyanide-based multi-component Ullmann-type reaction: an efficient access to novel nitrogen-containing pentacyclic compounds. ‎Mol. Divers., 19 (4): 797-805 (2015).